Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics

BACKGROUND: The programmed cell death-1/programmed cell death-1 ligand (PD-1/PD-L1) pathway plays a crucial role in tumor evasion. This study evaluated the association between circulating PD-L1 expression and clinical characteristics in patients with advanced non-small cell lung cancer (NSCLC). METH...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Thorac Cancer
Päätekijät: Zhang, Jie, Gao, Jing, Li, Yanyan, Nie, Jun, Dai, Ling, Hu, Weiheng, Chen, Xiaoling, Han, Jindi, Ma, Xiangjuan, Tian, Guangming, Wu, Di, Shen, Lin, Fang, Jian
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: John Wiley & Sons, Ltd 2015
Aiheet:
Original Articles
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4511334/
https://ncbi.nlm.nih.gov/pubmed/26273411
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12247
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia